Since in the present study, participants’ BMI has been unaffected by soy isoflavone supplementation, thus, an increasing trend in fetuin A level could be described in this way.
← all excerpts
The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A.
1
—
—